Relativity Logo
    Relativity
    Relativity Logo
    Relativity
    IdeasPortfoliosEvents
    Companies/APRE

    Aprea Therapeutics, Inc.(APRE)

    Biotechnology
    Oncology Biotech
    BusinessManagementInsider TradingIndustryFinancialsTranscripts
    Company Summary Stats
    H.BearBearishNeutralBullishH.Bull
    50.0
    Insider Trading Score
    Peer Group Scores
    ACRV
    68    IMA
    59    ALXO
    58    APRE
    50    PRLD
    50    AKTX
    50    ZNTL
    50    PMVP
    50    ERAS
    50    ARVN
    42
    Recent Insider Trades
    Filing DateInsiderType10b5-1Net SharesOwnership changeShares ownedAvg. PriceValueFiling
    2026-04-01
    Hamill John P.
    SrVP/CFO/Prin Fin & Acct Ofcr
    Purchase
    		+61,956
    +185.31%95,389
    		$0.40$24,999View SEC filing
    2026-04-01
    Peters Richard
    Director
    Purchase
    		+247,830
    +100.00%247,830
    		$0.40$99,999View SEC filing
    2026-02-02
    Gilad Oren
    President/CEO
    Purchase
    		+56,200
    +17.60%375,520
    		$0.45$25,009View SEC filing
    2026-02-02
    Hamill John P.
    SrVP/CFO/Prin Fin & Acct Ofcr
    Purchase
    		+11,400
    +51.74%33,433
    		$0.45$5,073View SEC filing
    2025-12-11
    Duey Marc
    Director
    Purchase
    		+42,918
    +20.07%256,757
    		$0.58$25,000View SEC filing
    2025-12-11
    Hamill John P.
    SrVP/CFO/Prin Fin & Acct Ofcr
    Purchase
    		+10,000
    +56.39%27,733
    		$0.58$5,825View SEC filing
    2025-12-11
    Gilad Oren
    President/CEO
    Purchase
    		+42,918
    +14.09%347,420
    		$0.58$25,000View SEC filing
    2025-04-04
    Gilad Oren
    President/CEO
    Purchase
    		+5,500
    +1.61%347,420
    		$1.84$10,110View SEC filing
    2024-10-25
    Duey Marc
    Director
    Sale
    		-6,462
    -2.68%234,253
    		$4.58$29,583View SEC filing
    2024-10-24
    Gilad Oren
    President/CEO
    Purchase
    		+500
    +0.15%335,195
    		$3.92$1,958View SEC filing
    2024-10-17
    Duey Marc
    Director
    Purchase
    		+30,000
    +14.24%240,715
    		$4.39$131,700View SEC filing
    2024-10-16
    Gilad Oren
    President/CEO
    Purchase
    		+250
    +0.07%334,695
    		$2.90$725View SEC filing
    2024-10-16
    Duey Marc
    Director
    Purchase
    		+190
    +0.09%210,715
    		$2.58$490View SEC filing
    2024-10-16
    Hamill John P.
    SrVP/CFO/Prin Fin & Acct Ofcr
    Purchase
    		+50
    +0.26%19,368
    		$2.46$123View SEC filing
    2024-10-15
    Seizinger Bernd R.
    Director
    Purchase
    		+10,000
    +28.79%44,730
    		$2.68$26,800View SEC filing
    2024-10-15
    Gilad Oren
    President/CEO
    Purchase
    		+1,150
    +0.35%334,445
    		$2.58$2,971View SEC filing
    2024-10-15
    Hamill John P.
    SrVP/CFO/Prin Fin & Acct Ofcr
    Purchase
    		+450
    +2.38%19,318
    		$2.61$1,175View SEC filing
    2024-03-14
    Hamill John P.
    SrVP/CFO/Prin Fin & Acct Ofcr
    Purchase
    		+2,020
    +14.98%15,503
    		$3.65$7,363View SEC filing
    2024-03-14
    Seizinger Bernd R.
    Director
    Purchase
    		+13,720
    +68.72%33,685
    		$3.65$50,009View SEC filing
    2024-03-14
    HENNEMAN JOHN B III
    Director
    Purchase
    		+13,720
    +1072.71%14,999
    		$3.65$50,009View SEC filing
    2024-03-14
    Gilad Oren
    President, CEO
    Purchase
    		+4,000
    +1.25%324,770
    		$3.65$14,580View SEC filing
    2023-06-08
    Seizinger Bernd R.
    Director
    Purchase
    		+10,097
    +62.22%26,325
    		$3.66$36,957View SEC filing
    2022-05-19
    Seizinger Bernd R.
    Director
    Purchase
    		+50,000
    +18.62%318,580
    		$0.71$35,500View SEC filing
    2022-05-19
    SCHADE CHRISTIAN S
    Chairman & CEO
    Purchase
    		+37,500
    +14.70%292,616
    		$0.64$24,124View SEC filing
    2022-03-01
    Attar Eyal C.
    SVP, Chief Medical Officer
    Sale
    		-36,000
    -43.37%47,000
    		$1.73$62,280View SEC filing

    1-25 of 54

    Page 1 of 3